Published

A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychedelic medicine (New Rochelle, N.Y.)
Date: 2023-03-01
Source: PubMed
DOI: 10.1089/psymed.2022.0002
PubMed: 37337526

Authors

Nayak SM Bari BA Yaden DB Spriggs MJ Rosas FE Peill JM Giribaldi B Erritzoe D Nutt DJ Carhart-Harris R

Watch author

Derived topics and classifications

psilocybin Depression Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.2023-03-01

Related papers

Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent EvidenceCurrent Psychopharmacologye · 2024-07-04 Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-09